Mimedx (MDXG) Operating Margin (2011 - 2026)
Mimedx (MDXG) reported Operating Margin of 27.21% for Q1 2026, down 3656.0% on a YoY basis from 0.77% in Q1 2025, and down 252.44% sequentially from 17.85% in Q4 2025.
Mimedx (MDXG) Operating Margin (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 16 years of Operating Margin data on file, last reported at 27.21% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 3656.0% year-over-year to 27.21%; the trailing twelve-month figure through Mar 2026 stood at 10.17% (down 513.0% YoY), and the FY2025 full-year result was 15.26%, down 161.0% from the prior year.
- Operating Margin retreated to 27.21% in Q1 2026, from 17.85% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 26.89% in Q2 2024 to a low of 27.21% in Q1 2026.
- A 5-year average of 6.97% and a median of 13.28% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin soared 2775 bps in 2023 and tumbled 3656 bps in 2026, its largest moves.
- Tracing MDXG's Operating Margin over 5 years: stood at 15.21% in 2022, then advanced by 17 bps to 17.84% in 2023, then tumbled by 33 bps to 11.9% in 2024, then jumped by 50 bps to 17.85% in 2025, then sank by 252 bps to 27.21% in 2026.
- Business Quant data shows MDXG's Operating Margin at 27.21% in Q1 2026, 17.85% in Q4 2025, and 19.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | -27.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.21% |
| Dec 31, 2025 | 17.85% |
| Sep 30, 2025 | 19.51% |
| Jun 30, 2025 | 12.55% |
| Mar 31, 2025 | 9.35% |
| Dec 31, 2024 | 11.90% |
| Sep 30, 2024 | 13.28% |
| Jun 30, 2024 | 26.89% |
| Mar 31, 2024 | 15.58% |
| Dec 31, 2023 | 17.84% |
| Sep 30, 2023 | 13.61% |
| Jun 30, 2023 | 13.34% |
| Mar 31, 2023 | -0.47% |
| Dec 31, 2022 | 15.21% |
| Sep 30, 2022 | -10.49% |
| Jun 30, 2022 | -14.41% |
| Mar 31, 2022 | -15.79% |
| Dec 31, 2021 | 2.53% |
| Sep 30, 2021 | -1.70% |
| Jun 30, 2021 | -0.60% |